Ferring and ICF to Develop IBD Treatment for Anal Fissures

Ferring and ICF to Develop IBD Treatment for Anal Fissures
Ferring Pharmaceuticals is collaborating with the Instituto de Ciencias Farmaceuticas (ICF, based in Brazil) to develop a potential new treatment for anal fissures for patients with inflammatory bowel disease (IBD). The mucoadhesive rectal delivery system for anal fissures aims to improve quality of care for patients with IBD, a common complication that has frequently been overlooked. Currently

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *